| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arvinas, Inc. (ARVN) has 11 insiders with recent SEC Form 4 filings, including 7 buys and 13 sells. ARVN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 202.5K | $1.55M | - | |
| CFO | 164.4K | $1.26M | - | |
| Dir | 76.0K | $583.1K | - | |
| Dir | 39.4K | $302.4K | - | |
| Other | 31.7K | $243.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2019 | Taylor Ian74 | Chief Scientific Officer | Sell | 10,000 | $21.86 | $218,614.00 | -6.2% | |
| Jul 29, 2019 | Cassidy Sean A78 | Chief Financial Officer | Sell | 11,945 | $26.22 | $313,245.13 | -2.4% | |
| Jun 28, 2019 | 5am Ventures Iii, L.P. | 10% Owner | Sell | 810,000 | $21.87 | $17,714,700.00 | -9.6% | |
| Jun 7, 2019 | 5am Ventures Iii, L.P. | 10% Owner | Sell | 190,000 | $19.65 | $3,733,500.00 | -4.1% | |
| Mar 29, 2019 | Taylor Ian74 | Chief Scientific Officer | Buy | 1,000 | $14.66 | $14,660.30 | +1.2% | |
| Mar 28, 2019 | 5am Ventures Iii, L.P. | 10% Owner | Sell | 361,129 | $14.16 | $5,112,683.82 | -7.2% | |
| Mar 28, 2019 | Shannon Timothy M82 | Director | Buy | 3,500 | $14.69 | $51,409.75 | +6.3% | |
| Oct 1, 2018 | Flynn James E62 | 10% Owner, Possible Member Of A 10% Group | Buy | 312,500 | $16.00 | $5,000,000.00 | +33.9% | |
| Oct 1, 2018 | Ra Capital Management, LLC53 | Former 10% Owner | Buy | 1,000,000 | $16.00 | $16,000,000.00 | +46.8% | |
| Oct 1, 2018 | Shannon Timothy M82 | Director | Buy | 4,000 | $16.00 | $64,000.00 | +7.8% |